REFERENCES
1. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol 2011;26 Suppl 1:S1-58.
3. Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL. Limitations of current Parkinson’s disease therapy. Ann Neurol 2003;53 Suppl 3:S3-12; discussion S12-5.
4. Ceravolo R, Rossi C, Del Prete E, Bonuccelli U. A review of adverse events linked to dopamine agonists in the treatment of Parkinson’s disease. Expert Opin Drug Saf 2016;15:181-98.
5. Heumann R, Moratalla R, Herrero MT, et al. Dyskinesia in Parkinson’s disease: mechanisms and current non-pharmacological interventions. J Neurochem 2014;130:472-89.
6. Goodwill AM, Lum JAG, Hendy AM, et al. Using non-invasive transcranial stimulation to improve motor and cognitive function in Parkinson’s disease: a systematic review and meta-analysis. Sci Rep 2017;7:14840.
7. Li S, Jiao R, Zhou X, Chen S. Motor recovery and antidepressant effects of repetitive transcranial magnetic stimulation on Parkinson disease: a PRISMA-compliant meta-analysis. Medicine 2020;99:e19642.
8. Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009;120:2008-39.
9. Rossini PM, Burke D, Chen R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol 2015;126:1071-107.
10. Deng ZD, Lisanby SH, Peterchev AV. Coil design considerations for deep transcranial magnetic stimulation. Clin Neurophysiol 2014;125:1202-12.
11. Obeso JA, Marin C, Rodriguez-Oroz C, et al. The basal ganglia in Parkinson’s disease: current concepts and unexplained observations. Ann Neurol 2008;64 Suppl 2:S30-46.
12. Wang JX, Rogers LM, Gross EZ, et al. Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science 2014;345:1054-7.
13. DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007;64:20-4.
14. Nambu A, Tokuno H, Takada M. Functional significance of the cortico-subthalamo-pallidal ‘hyperdirect’ pathway. Neurosci Res 2002;43:111-7.
15. Xie CL, Shao B, Chen J, Zhou Y, Lin SY, Wang WW. Effects of neurostimulation for advanced Parkinson’s disease patients on motor symptoms: a multiple-treatments meta-analysas of randomized controlled trials. Sci Rep 2016;6:25285.
16. Peng L, Fu J, Ming Y, Zeng S, He H, Chen L. The long-term efficacy of STN vs GPi deep brain stimulation for Parkinson disease: a meta-analysis. Medicine 2018;97:e12153.
17. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurol 2006;5:578-88.
18. Schaltenbrand G, Wahren W. Atlas for stereotaxy of the human brain. Georg Thieme. 1977. Available from: https://www.semanticscholar.org/paper/Atlas-for-Stereotaxy-of-the-Human-Brain-Schaltenbrand-Wahren/d181ed3002e0d5c503be5a565e500d1aa181220b. [Last accessed on 8 May 2024].
19. Chandran AS, Bynevelt M, Lind CRP. Magnetic resonance imaging of the subthalamic nucleus for deep brain stimulation. J Neurosurg 2016;124:96-105.
20. Ashkan K, Blomstedt P, Zrinzo L, et al. Variability of the subthalamic nucleus: the case for direct MRI guided targeting. Br J Neurosurg 2007;21:197-200.
21. Andrade-Souza YM, Schwalb JM, Hamani C, et al. Comparison of three methods of targeting the subthalamic nucleus for chronic stimulation in Parkinson’s disease. Neurosurgery 2008;62 Suppl 2:875-83.
22. Lozano CS, Ranjan M, Boutet A, et al. Imaging alone versus microelectrode recording-guided targeting of the STN in patients with Parkinson’s disease. J Neurosurg 2018;130:1847-52.
23. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15:155-63.
24. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
25. Fernández-Seara MA, Mengual E, Vidorreta M, et al. Resting state functional connectivity of the subthalamic nucleus in Parkinson’s disease assessed using arterial spin-labeled perfusion fMRI. Hum Brain Mapp 2015;36:1937-50.
26. Baudrexel S, Witte T, Seifried C, et al. Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson’s disease. Neuroimage 2011;55:1728-38.
27. Vitek JL, Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. Ann Neurol 2000;47:S131-40.
28. Chen KHS, Chen R. Invasive and noninvasive brain stimulation in Parkinson’s disease: clinical effects and future perspectives. Clin Pharmacol Ther 2019;106:763-75.
29. Ahdab R, Ayache SS, Brugières P, Farhat WH, Lefaucheur JP. The hand motor hotspot is not always located in the hand knob: a neuronavigated transcranial magnetic stimulation study. Brain Topogr 2016;29:590-7.
30. Cincotta M, Giovannelli F, Borgheresi A, et al. Optically tracked neuronavigation increases the stability of hand-held focal coil positioning: evidence from “transcranial” magnetic stimulation-induced electrical field measurements. Brain Stimul 2010;3:119-23.
31. Julkunen P, Säisänen L, Danner N, et al. Comparison of navigated and non-navigated transcranial magnetic stimulation for motor cortex mapping, motor threshold and motor evoked potentials. Neuroimage 2009;44:790-5.
32. Weiss C, Nettekoven C, Rehme AK, et al. Mapping the hand, foot and face representations in the primary motor cortex - retest reliability of neuronavigated TMS versus functional MRI. Neuroimage 2013;66:531-42.
33. Wong JK, Cauraugh JH, Ho KWD, et al. STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 2019;58:56-62.
34. Fox MD, Buckner RL, Liu H, Chakravarty MM, Lozano AM, Pascual-Leone A. Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases. Proc Natl Acad Sci U S A 2014;111:E4367-75.
35. Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry 2012;72:595-603.
36. Weigand A, Horn A, Caballero R, et al. Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites. Biol Psychiatry 2018;84:28-37.
37. Cash RFH, Cocchi L, Lv J, Fitzgerald PB, Zalesky A. Functional magnetic resonance imaging-guided personalization of transcranial magnetic stimulation treatment for depression. JAMA Psychiatry 2021;78:337-9.
38. Paychiatric News. FDA clears accelerated TMS protocol for depression. Available from: https://psychnews.psychiatryonline.org/doi/full/10.1176/appi.pn.2022.10.10.40. [Last accessed on 8 May 2024].
39. Isaacs BR, Forstmann BU, Temel Y, Keuken MC. The connectivity fingerprint of the human frontal cortex, subthalamic nucleus, and striatum. Front Neuroanat 2018;12:60.
40. Shen B, Gao Y, Zhang W, et al. Resting state fMRI reveals increased subthalamic nucleus and sensorimotor cortex connectivity in patients with Parkinson’s disease under medication. Front Aging Neurosci 2017;9:74.
41. Wang Z, Chen H, Ma H, Ma L, Wu T, Feng T. Resting-state functional connectivity of subthalamic nucleus in different Parkinson’s disease phenotypes. J Neurol Sci 2016;371:137-47.
42. Arnold Anteraper S, Guell X, Whitfield-Gabrieli S, et al. Resting-state functional connectivity of the subthalamic nucleus to limbic, associative, and motor networks. Brain Connect 2018;8:22-32.
43. Brunenberg EJL, Moeskops P, Backes WH, et al. Structural and resting state functional connectivity of the subthalamic nucleus: identification of motor STN parts and the hyperdirect pathway. PLoS One 2012;7:e39061.
44. Lambert C, Zrinzo L, Nagy Z, et al. Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging. Neuroimage 2012;60:83-94.
45. Guehl D, Edwards R, Cuny E, et al. Statistical determination of the optimal subthalamic nucleus stimulation site in patients with Parkinson disease. J Neurosurg 2007;106:101-10.
46. Avecillas-Chasin JM, Alonso-Frech F, Nombela C, Villanueva C, Barcia JA. Stimulation of the tractography-defined subthalamic nucleus regions correlates with clinical outcomes. Neurosurgery 2019;85:E294-303.
